miRNAs and resistance to EGFR—TKIs in EGFR-mutant non-small cell lung cancer: beyond ‘traditional mechanisms’ of resistance

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have dramatically changed the prognosis of advanced non-small cell lung cancers (NSCLCs) that harbour specific EGFR activating mutations. However, the efficacy of an EGFR-TKI is limited by the onset of acquired resistance, usu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Ricciuti, Biagio, Mecca, Carmen, Cenci, Matteo, Leonardi, Giulia Costanza, Perrone, Lorenzo, Mencaroni, Clelia, Crinò, Lucio, Grignani, Francesco, Baglivo, Sara, Chiari, Rita, Sidoni, Angelo, Paglialunga, Luca, Currà, Maria Francesca, Murano, Emanuele, Minotti, Vincenzo, Metro, Giulio
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4583238/
https://ncbi.nlm.nih.gov/pubmed/26435742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.569
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados